Corrigendum to Active Extramedullary Disease Predicts ICANS and Early ICAHT after CAR-T Therapy in Multiple Myeloma Transplantation and Cellular Therapy 31/2S (2025) S409

Andrew J. Portuguese; Emily C. Liang; Jennifer J. Huang; Lorenzo Iovino; Natalie Wuliji; Danai Dima; Rahul Banerjee; Mary L. Kwok; Kara I. Cicero; Mazyar Shadman; Andrew J. Cowan; Jordan Gauthier

doi:10.1016/j.jtct.2025.03.009

Corrigendum to Active Extramedullary Disease Predicts ICANS and Early ICAHT after CAR-T Therapy in Multiple Myeloma Transplantation and Cellular Therapy 31/2S (2025) S409

Andrew J. Portuguese^*
, Emily C. Liang
, Jennifer J. Huang
, Lorenzo Iovino
, Natalie Wuliji
, Danai Dima
, Rahul Banerjee
, Mary L. Kwok
, Kara I. Cicero
, Mazyar Shadman
, Andrew J. Cowan
, Jordan Gauthier

^*Corresponding author for this work

Medicine

Research output: Contribution to journal › Comment/debate

Abstract

The authors regret that the acronym ICAHT was incorrectly expanded in the original article. The correct expansion of ICAHT is “immune effector cell-associated hematotoxicity,” not “immune effector cell-associated hemophagocytic syndrome.” The authors would like to apologize for any inconvenience caused.

Original language	English
Pages (from-to)	630
Number of pages	1
Journal	Transplantation and Cellular Therapy
Volume	32
Issue number	5
DOIs	https://doi.org/10.1016/j.jtct.2025.03.009
State	Published - May 2026

Access to Document

10.1016/j.jtct.2025.03.009

Cite this

Portuguese, A. J., Liang, E. C., Huang, J. J., Iovino, L., Wuliji, N., Dima, D., Banerjee, R., Kwok, M. L., Cicero, K. I., Shadman, M., Cowan, A. J., & Gauthier, J. (2026). Corrigendum to Active Extramedullary Disease Predicts ICANS and Early ICAHT after CAR-T Therapy in Multiple Myeloma Transplantation and Cellular Therapy 31/2S (2025) S409. Transplantation and Cellular Therapy, 32(5), 630. https://doi.org/10.1016/j.jtct.2025.03.009

@article{6acecd684d03482da43a1eb774dbaf94,

title = "Corrigendum to Active Extramedullary Disease Predicts ICANS and Early ICAHT after CAR-T Therapy in Multiple Myeloma Transplantation and Cellular Therapy 31/2S (2025) S409",

abstract = "The authors regret that the acronym ICAHT was incorrectly expanded in the original article. The correct expansion of ICAHT is {\textquotedblleft}immune effector cell-associated hematotoxicity,{\textquotedblright} not {\textquotedblleft}immune effector cell-associated hemophagocytic syndrome.{\textquotedblright} The authors would like to apologize for any inconvenience caused.",

author = "Portuguese, \{Andrew J.\} and Liang, \{Emily C.\} and Huang, \{Jennifer J.\} and Lorenzo Iovino and Natalie Wuliji and Danai Dima and Rahul Banerjee and Kwok, \{Mary L.\} and Cicero, \{Kara I.\} and Mazyar Shadman and Cowan, \{Andrew J.\} and Jordan Gauthier",

note = "Publisher Copyright: {\textcopyright} 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.",

year = "2026",

month = may,

doi = "10.1016/j.jtct.2025.03.009",

language = "English",

volume = "32",

pages = "630",

journal = "Transplantation and Cellular Therapy",

issn = "2666-6367",

publisher = "Elsevier B.V.",

number = "5",

}

Portuguese, AJ, Liang, EC, Huang, JJ, Iovino, L, Wuliji, N, Dima, D, Banerjee, R, Kwok, ML, Cicero, KI, Shadman, M, Cowan, AJ & Gauthier, J 2026, 'Corrigendum to Active Extramedullary Disease Predicts ICANS and Early ICAHT after CAR-T Therapy in Multiple Myeloma Transplantation and Cellular Therapy 31/2S (2025) S409', Transplantation and Cellular Therapy, vol. 32, no. 5, pp. 630. https://doi.org/10.1016/j.jtct.2025.03.009

Corrigendum to Active Extramedullary Disease Predicts ICANS and Early ICAHT after CAR-T Therapy in Multiple Myeloma Transplantation and Cellular Therapy 31/2S (2025) S409. / Portuguese, Andrew J.; Liang, Emily C.; Huang, Jennifer J. et al.
In: Transplantation and Cellular Therapy, Vol. 32, No. 5, 05.2026, p. 630.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Corrigendum to Active Extramedullary Disease Predicts ICANS and Early ICAHT after CAR-T Therapy in Multiple Myeloma Transplantation and Cellular Therapy 31/2S (2025) S409

AU - Portuguese, Andrew J.

AU - Liang, Emily C.

AU - Huang, Jennifer J.

AU - Iovino, Lorenzo

AU - Wuliji, Natalie

AU - Dima, Danai

AU - Banerjee, Rahul

AU - Kwok, Mary L.

AU - Cicero, Kara I.

AU - Shadman, Mazyar

AU - Cowan, Andrew J.

AU - Gauthier, Jordan

N1 - Publisher Copyright: © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.

PY - 2026/5

Y1 - 2026/5

N2 - The authors regret that the acronym ICAHT was incorrectly expanded in the original article. The correct expansion of ICAHT is “immune effector cell-associated hematotoxicity,” not “immune effector cell-associated hemophagocytic syndrome.” The authors would like to apologize for any inconvenience caused.

AB - The authors regret that the acronym ICAHT was incorrectly expanded in the original article. The correct expansion of ICAHT is “immune effector cell-associated hematotoxicity,” not “immune effector cell-associated hemophagocytic syndrome.” The authors would like to apologize for any inconvenience caused.

UR - https://www.scopus.com/pages/publications/105002801440

U2 - 10.1016/j.jtct.2025.03.009

DO - 10.1016/j.jtct.2025.03.009

M3 - Comment/debate

AN - SCOPUS:105002801440

SN - 2666-6367

VL - 32

SP - 630

JO - Transplantation and Cellular Therapy

JF - Transplantation and Cellular Therapy

IS - 5

ER -

Corrigendum to Active Extramedullary Disease Predicts ICANS and Early ICAHT after CAR-T Therapy in Multiple Myeloma Transplantation and Cellular Therapy 31/2S (2025) S409

Abstract

Access to Document

Fingerprint

Cite this